BAMCO Inc
PCRX icon

BAMCO Inc’s Pacira BioSciences PCRX Stock Holding History

BAMCO Inc’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-72,334
Closed -$3.45M – 329
2017
Q2 		$3.45M Buy
72,334
+23,200
+47% +$1.08M 0.02% 246
2017
Q1 		$2.24M Buy
49,134
+24,879
+103% +$1.08M 0.01% 255
2016
Q4 		$783K Buy
24,255
+2,334
+11% +$77.9K ﹤0.01% 294
2016
Q3 		$750K Sell
21,921
-34,430
-61% -$1.35M ﹤0.01% 283
2016
Q2 		$1.9M Buy
56,351
+40,140
+248% +$1.97M 0.01% 243
2016
Q1 		$859K Buy
16,211
+3,288
+25% +$192K ﹤0.01% 259
2015
Q4 		$992K Buy
12,923
+6,023
+87% +$341K ﹤0.01% 276
2015
Q3 		$284K Buy
+6,900
New +$423K ﹤0.01% 333
2015
Q2 		– Sell
-82,380
Closed -$7.32M – 359
2015
Q1 		$7.32M Buy
82,380
+15,292
+23% +$1.55M 0.03% 251
2014
Q4 		$5.95M Buy
67,088
+4,949
+8% +$468K 0.02% 261
2014
Q3 		$6.02M Sell
62,139
-92,254
-60% -$8.97M 0.02% 260
2014
Q2 		$14.2M Buy
154,393
+137,293
+803% +$10.5M 0.06% 222
2014
Q1 		$1.2M Buy
17,100
+10,605
+163% +$721K ﹤0.01% 303
2013
Q4 		$373K Buy
+6,495
New +$342K ﹤0.01% 315

Other funds holding PCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PC
PointState Capital New York $4.31B AUM 42.31% 1-Year Est. Return